ArticleJournal for immunotherapy of cancer2025

Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.